#United States #New York #Class Action #Gross Law Firm #Reckitt Benckiser

Legal Alert: Class Action Lawsuit Against Reckitt Benckiser Group plc

The Gross Law Firm has recently issued a significant notice to shareholders of Reckitt Benckiser Group plc (OTC PINK: RBGLY), notifying them about a pending class action lawsuit. This lawsuit is critical for investors who purchased shares during the defined class period, particularly between January 13, 2021, and July 28, 2024. The deadline for potential lead plaintiffs to register is set for August 4, 2025.

Overview of the Class Action

The allegations outlined in the lawsuit suggest that Reckitt Benckiser misled investors by failing to disclose crucial information regarding the risks associated with its product, Enfamil, specifically relating to preterm infants. The claims outline that these infants may be at an increased risk of developing a serious condition known as necrotizing enterocolitis (NEC) as a result of consuming the company's cow's milk-based formula. This vital information was not disclosed to shareholders, and its omission has adversely affected the company's credibility and stock value.

Allegations Against Reckitt Benckiser

The complaint alleges multiple issues:
1. The risk of NEC for preterm infants consuming Enfamil was not disclosed to shareholders.
2. The impact on Reckitt’s sales and ongoing legal liabilities related to these health issues were not communicated.
3. Positive statements about the company’s business operations lacked a basis in truth due to these undisclosed risks.

Given these claims, shareholders who believe they have been affected are strongly encouraged to contact the Gross Law Firm to discuss potential lead plaintiff appointments. Being appointed as a lead plaintiff is not a mandatory requirement for participating in any potential recovery related to the lawsuit.

Important Dates for Shareholders

The lead plaintiff registration deadline is critical for all stockholders, as it marks a pivotal point in the litigation process. Shareholders interested in joining the lawsuit must register their information before the August 4, 2025 deadline. This registration will provide them access to a portfolio monitoring tool that will keep them updated on the status of the case throughout its duration, ensuring they are informed of any developments.

Why Choose the Gross Law Firm?

The Gross Law Firm is well-known for its dedication to protecting the rights of investors against deceitful and fraudulent business practices. The firm takes its commitment seriously to hold corporations accountable for transparent and fair practices, ensuring they don’t mislead their stakeholders. Essentially, the firm aims to recover losses suffered by investors due to ineffective corporate disclosures.

Next Steps for Investors

Shareholders who purchased RBGLY shares within the specified timeframe are strongly advised to take action without delay. Registration is straightforward, and participation comes with no financial obligations. For those who believe they qualify to be lead plaintiffs, the Gross Law Firm will guide them through the required processes. Additionally, relevant links have been provided in the notice for ease of access to registration.

For more information or to register as a potential claimant, visit Gross Law Firm’s website.

This scenario underlines the importance of vigilance and action among investors, emphasizing the necessity of being informed about the integrity and operational transparency of the companies they invest in. The repercussions of this case could have substantial ramifications for Reckitt Benckiser and its stakeholders, and engaging with the lawsuit can be a vital step towards addressing allegations of corporate malpractice.